Saltar al contenido

Evolent Health, Inc. (EVH) stock: revenue, earnings & dividend

Evolent Health, Inc. (EVH, NYSE): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener EVH · NYSE Dienstleistungen US-VA

Key figures

Fiscal year
2025
Revenue
1.88 bn $
Revenue growth
-26.6 %
Revenue growth 5y (p.a.)
15.2 %
Net income
-579.4 m $
Net margin
-30.9 %
Operating margin
-21.9 %
Earnings per share (diluted)
-5.07 $
Dividend per share
–
Payout ratio
–
Consecutive dividend years
–
Consecutive dividend raises
–
Dividend growth 5y (p.a.)
–
Total assets
1.9 bn $
Equity
415 m $
Equity ratio
21.9 %
Return on equity
-139.6 %
Cash
152 m $
Operating cash flow
38.8 m $
Free cash flow
–
Shares outstanding
113,105,519

History

Revenue by fiscal year

2016 254 m $
2017 435 m $
2018 627 m $
2019 846 m $
2020 925 m $
2021 908 m $
2022 1.35 bn $
2023 1.96 bn $
2024 2.55 bn $
2025 1.88 bn $

Net income by fiscal year

2016 -159.74 m $
2017 -60.67 m $
2018 -52.66 m $
2019 -301.97 m $
2020 -334.25 m $
2021 -37.6 m $
2022 -19.2 m $
2023 -142.3 m $
2024 -93.5 m $
2025 -579.4 m $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
20251.88 bn $-579.4 m $-5.07 $–38.8 m $
20242.55 bn $-93.5 m $-0.81 $–18.8 m $
20231.96 bn $-142.3 m $-1.28 $–143 m $
20221.35 bn $-19.2 m $-0.20 $–-11.55 m $
2021908 m $-37.6 m $-0.44 $–38.7 m $
2020925 m $-334.25 m $-3.94 $–-16.23 m $
2019846 m $-301.97 m $-3.67 $–-42.65 m $
2018627 m $-52.66 m $––-20.65 m $
2017435 m $-60.67 m $-0.94 $–-27.96 m $
2016254 m $-159.74 m $-3.55 $–-35.51 m $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)